Fluorescent In Situ Hybridization As a Primary Test for HER2 Status in Breast Cancer: Controversies Reply

被引：4
|
作者：
Sauter, Guido [1 ]
Lee, James A. [2 ]
Slamon, Dennis J. [3 ]
Press, Michael F. [4 ,5 ]
机构：
[1] Univ Hamburg, Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany
[2] Altarum Inst, Ann Arbor, MI USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Keck Sch Med, Dept Pathol, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90095 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 05期
关键词：
COST-EFFECTIVENESS ANALYSIS; RECEPTOR; 2; ASSESSMENT; GENE AMPLIFICATION; IMMUNOHISTOCHEMICAL ASSAY; FISH; TRASTUZUMAB; CONCORDANCE; CARCINOMAS; EXPRESSION; HERCEPTEST;
D O I：
10.1200/JCO.2009.25.3930
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E85 / E88
页数：4
相关论文
共 50 条
  • [31] Evaluation of HER-2/neu Gene Amplification by Fluorescence In Situ Hybridization and Immunohistochemistry in Saudi Female Breast Cancer
    Al-Khattabi, Heba
    Kelany, Abdelhakeem
    Buhmeida, Abdelbaset
    Al-Maghrabi, Jaudah
    Lari, Sahira
    Chaudhary, Adeel
    Gari, Mamdooh
    Abuzenadah, Adel
    Al-Qahtani, Mohmmad
    ANTICANCER RESEARCH, 2010, 30 (10) : 4081 - 4088
  • [32] Systematic Review of HER2 Breast Cancer Testing
    Cuadros, Marta
    Villegas, Roman
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2009, 17 (01) : 1 - 7
  • [33] HER2/neu Status in Breast Cancer Specimens: Comparison of Immunohistochemistry (IHC) and Fluorescence in situ Hybridization (FISH) Methods
    Saglican, Yesim
    Ince, Umit
    INTERNATIONAL JOURNAL OF MORPHOLOGY, 2015, 33 (02): : 737 - 742
  • [34] Comparison of Fluorescence In Situ Hybridization (FISH) and Dual-ISH (DISH) in the Determination of HER2 Status in Breast Cancer
    Mansfield, Aaron S.
    Sukov, William R.
    Eckel-Passow, Jeanette E.
    Sakai, Yuta
    Walsh, Frank J.
    Lonzo, Melissa
    Wiktor, Anne E.
    Dogan, Ahmet
    Jenkins, Robert B.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 139 (02) : 144 - 150
  • [35] HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
    Hou, Yanjun
    Nitta, Hiroaki
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 89 - 95
  • [36] Evaluation of analytical accuracy of HER2 status in patients with breast cancer Comparison of HER2 GPA with HER2 IHC and HER2 FISH
    Jensen, Steffen Grann
    Thomas, Peter Engel
    Christensen, Ib Jarle
    Balslev, Eva
    Hansen, Alastair
    Hogdall, Estrid
    APMIS, 2020, 128 (11) : 573 - 582
  • [37] HER2 status in bilateral breast cancer
    Crowe, Joseph P.
    Patrick, Rebecca J.
    Rybicki, Lisa A.
    Budd, G. Thomas
    Escobar, Pedro F.
    Tubbs, Raymond R.
    Hicks, David G.
    INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE, 2006, 51 (05) : 219 - 223
  • [38] Concomitant Detection of HER2 Protein and Gene Alterations by Immunohistochemistry (IHC) and Silver Enhanced In Situ Hybridization (SISH) Identifies HER2 Positive Breast Cancer with and without Gene Amplification
    Varga, Zsuzsanna
    Tubbs, Raymond R.
    Moch, Holger
    PLOS ONE, 2014, 9 (08):
  • [39] HER2 Dual In Situ Hybridization Correlations and Cautions
    Troxell, Megan
    Sibley, Richard K.
    West, Robert B.
    Bean, Gregory R.
    Allison, Kimberly H.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2020, 144 (12) : 1525 - 1534
  • [40] Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status
    Laidi, Fatna
    Bouziane, Amal
    Lakhdar, Amina
    Khabouze, Samira
    Rhrab, Brahim
    Zaoui, Fatima
    ONCOTARGETS AND THERAPY, 2014, 7 : 1285 - 1289
12345